how many people are on glp-1 drugs Drug Market: the rapid growth of the diabetes and obesity market Beyond Weight Loss: 59% of

Coskun, T

Finally, preoperative gastric ultrasound is here and now widely available for decision making

Systemic dyslipidemia in age-related macular degeneration: an updated systematic review and meta-analysis

Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus

The protective effects of GLP-1 RAs against cardiovascular events have been demonstrated in several studies, thus supporting their application in patients with heart failure with preserved ejection fraction and DM2 ( Taken together, GLP-1 is a major metabolic and regulatory hormone, with many potential therapeutic implications beyond glycemic control, encompassing cardiovascular protection, enhanced renal function, and the potential benefits in hepatic disease